Subtentorial astrocytomas in adults: treatment results

Viktor V. Gudkov, Liudmyla M. Verbova, Volodymyr O. Fedirko, Petro M. Onishchenko, Tetiana A. Malysheva, Oleksandr M. Lisyanyi, Oksana G. Chernenko, Dmytro M. Tsiurupa

Abstract


Objective. To study the clinical and morphological characteristics of subtentorial astrocyte, to prove the recommendations for therapeutic tactics in adults.

Materials and methods. A retrospective analysis was performed on 232 patients with astrocytomas of subtentorial localization (Grade I-IV) undergone the treatment in Romodanov Neurosurgery Institute in the period between 1988 and 2016.

Results. Overall, 20 (8.6%) patients had Grade I astrocytomas, 135(58,2%) – Grade II, 72 (31%) – Grade III and 5 (2.2%) – Grade IV. The main clinical manifestations included: headaches – 94%, coordination disturbances – 89%, nausea/vomiting – 47%. Morphological investigation has been performed. The basic clinical manifestations included headache (94%), disorders in static co-ordination – 89%, nausea and vomiting – 47%. All of the patients were operated. Ninety-seven (41.8%) patients underwent total resection, 51 (22%) – subtotal and 84 (36.2%) – partial. In the most of cases (142 patients), the tumor located in the hemisphere of cerebellum and in the vermis. A microscopic research demonstrated the variety of a histologic structure not only in the different cases, but also in the same tumor. Thirty-six (15.5%) patients were re-operated due to tumor.

Conclusions. Regardless of removed tumors volume, generally the astrocytomas of fossa posterior have favourable prognosis. Nevertheless, they require further investigations, especially Higth Grade III-IV.


Keywords


subtentorial astrocytomas; surgical treatment; recurrence disease; morphological characteristics

References


1. Babu R, Sharma R, Karikari IO, Owens TR, Friedman AH, Adamson C. Outcome and prognostic factors in adult cerebellar glioblastoma. J Clin Neurosci. 2013 Aug; 20(8):1117-21. [CrossRef] [PubMed]

2. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016 Jun;131(6):803-20. [CrossRef] [PubMed]

3. Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, Schьler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lьtolf UM, Kleihues P, Ohgaki H. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol. 2004;108(1):49-56. [CrossRef] [PubMed]

4. Kuroiwa T, Numaguchi Y, Rothman MI, Zoarski GH, Morikawa M, Zagardo MT, Kristt DA. Posterior fossa glioblastoma multiforme: MR findings. AJNR Am J Neuroradiol. 1995;16(3):583-9. [PubMed]

5. Matsumoto H, Yoshida Y. De novo cerebellar malignant glioma: A case report. Int J Surg Case Rep. 2016;22:28-31. [CrossRef] [PubMed] [PubMed Central]

6. Nikiforov BM, Matsko DE. Osobennosti opukholey golovnogo mozga u detey. Neyrokhirurgiya i nevrologiya detskogo vozrasta. Pediatric Neurosurgery and Neurology. 2002;(1). 21-7. Russian.

7. Viano JC, Herrera EJ, Suarez JC. Cerebellar astrocytomas: a 24-year experience. Childs Nerv Syst. 2001;17(10):607-10. [CrossRef] [PubMed]

8. Strauss I, Jonas-Kimchi T, Bokstein F, Blumenthal D, Roth J, Sitt R, Wilson J, Ram Z. Gliomas of the posterior fossa in adults. J Neurooncol. 2013 Dec;115(3):401-9. [CrossRef] [PubMed]

9. Ulitin AIu, Oliushin VE, Poliakov IV. [Epidemiology of primary brain tumors in Saint Petersburg]. Zh Vopr Neirokhir Im N N Burdenko. 2005 Jan-Mar;(1):6-11; discussion 11-2. Russian. [PubMed]

10. Khominskiy BS, Shamayev MI, Rasheyeva IG. Patologicheskaya i topograficheskaya kharakteristika gliom mediannykh i paramediannykh otdelov bol’shogo mozga. Problemy neyrokhirurgii. 1970;3:14-27. Russian.

11. Collins VP. Brain tumours: classification and genes. J Neurol Neurosurg Psychiatry. 2004 Jun;75 Suppl 2:ii2-11. [CrossRef] [PubMed] [PubMed Central]

12. Wade A, Hayhurst C, Amato-Watkins A, Lammie A, Leach P. Cerebellar pilocytic astrocytoma in adults: a management paradigm for a rare tumour. Acta Neurochir (Wien). 2013 Aug;155(8):1431-5. [CrossRef] [PubMed]

13. Bagley JH, Babu R, Friedman AH, Adamson C. Improved survival in the largest national cohort of adults with cerebellar versus supratentorial low-grade astrocytomas. Neurosurg Focus. 2013;34(2):E7. [CrossRef] [PubMed]

14. Johnson DR, Brown PD, Galanis E, Hammack JE. Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. J Neurooncol. 2012 May;108(1):187-93. [CrossRef] [PubMed]

15. Ryu HH, Jung TY, Lee GJ, Lee KH, Jung SH, Jung S, Baek HJ. Differences in the clinical courses of pediatric and adult pilocytic astrocytomas with progression: a single-institution study. Childs Nerv Syst. 2015 Nov;31(11):2063-9. [CrossRef] [PubMed]

16. Gaha M, Bouzayen F, Limam Y, Mokni M, Jemni-Gharbi H, Tlili-Graiess K. Pilocytic astrocytoma mimicking cavernous angioma: Imaging features and histological characteristics. Neurochirurgie. 2017 Sep;63(4):330-333. [CrossRef] [PubMed]

17. Prasad GL, Nandeesh BN, Menon GR. Hemorrhagic presentation of intracranial pilocytic astrocytomas: literature review. Neurosurg Rev. 2017 Oct 4. [CrossRef] [PubMed]

18. Sinha S, Kale SS, Chandra SP, Suri A, Mehta VS, Sharma BS. Brainstem gliomas: surgical indications and technical considerations in a series of 58 cases. Br J Neurosurg. 2014 Apr;28(2):220-5. [CrossRef] [PubMed]

19. Wilcox P, Li CC, Lee M, Shivalingam B, Brennan J, Suter CM, Kaufman K, Lum T, Buckland ME. Oligoastrocytomas: throwing the baby out with the bathwater? Acta Neuropathol. 2015 Jan;129(1):147-9. [CrossRef] [PubMed]

20. Nair S, Giannakopoulos G, Granick M, Solomon M, McCormack T, Black P. Surgical management of radiated scalp in patients with recurrent glioma. Neurosurgery. 1994;34(1):103-7. [CrossRef] [PubMed]

21. Olar A, Wani KM, Alfaro-Munoz KD, Heathcock LE, van Thuijl HF, Gilbert MR, Armstrong TS, Sulman EP, Cahill DP, Vera-Bolanos E, Yuan Y, Reijneveld JC, Ylstra B, Wesseling P, Aldape KD. IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas. Acta Neuropathol. 2015 Apr;129(4):585-96. [CrossRef] [PubMed]

22. DeVita VT. The James Ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer. Cancer. 1983;51(7):1209-20. [CrossRef] [PubMed]

23. Matsko D.E. O novoy klassifikatsii opukholey nervnoy sistemy VOZ. Neyrokhirurgiya i nevrologiya detskogo vozrasta. 2003 (1):76-9. Russian.

24. Robak K, Chuvashova O, Glavatskyi O. [Application data diff tensor imaging and MRI tractography in neurosurgery of the gliomas of motor area of the brain]. Neurology and neurosurgery. Eastern Europe. 2016;6(3):341-346. Russian. [eLIBRARY.RU]


GOST Style Citations






DOI: https://doi.org/10.25305/unj.117774

Copyright (c) 2018 Viktor V. Gudkov, Liudmyla M. Verbova, Volodymyr O. Fedirko, Petro M. Onishchenko, Tetiana A. Malysheva, Oleksandr M. Lisyanyi, Oksana G. Chernenko, Dmytro M. Tsiurupa

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.